NEVRO CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-12-18: Form 8-K; Period of report 2019-12-17; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
- 2019-11-06: Form 8-K; Period of report 2019-11-06; Description 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 2.02.
- 2019-08-08: Form 8-K; Period of report 2019-08-08; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2019-05-24: Form 8-K; Period of report 2019-05-20; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; Details 5.03.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2019-12-18 | 8-K | 2019-12-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | nvro-8k_20191217.htm | |
| 2019-11-06 | 8-K | 2019-11-06 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.02 On November 6, 2019, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and nine months ended September 30, 2019. | nvro-8k_20191106.htm |
| 2019-08-08 | 8-K | 2019-08-08 | 2.02 Results of Operations and Financial Condition | 2.02 On August 8, 2019, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and six months ended June 30, 2019. | nvro-8k_20190808.htm |
| 2019-05-24 | 8-K | 2019-05-20 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.03 On May 23, 2019, Nevro Corp.’s (“Nevro” or the “Company”) amendment to its amended and restated certificate of incorporation (the “Charter Amendment”) was filed with the Secretary of State of the State of Delaware and became effective. 5.07 On May 20, 2019, Nevro held its 2019 Annual Meeting. | nvro-8k_20190520.htm |
| 2019-05-09 | 8-K | 2019-05-08 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.02 On May 9, 2019, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months ended March 31, 2019. | nvro-8k_20190508.htm |
| 2019-03-20 | 8-K | 2019-03-18 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 5.02 Reference is made to the disclosures set forth in Item 1.01 above and incorporated in this Item 5.02 by reference. 8.01 On March 19, 2019, the Company issued a press release announcing the execution of the Agreement described in Item 1.01. | d710346d8k.htm |
| 2019-02-21 | 8-K | 2019-02-21 | 2.02 Results of Operations and Financial Condition | 2.02 On February 21, 2019, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months and full year ended December 31, 2018. | nvro-8k_20190221.htm |
| 2019-01-07 | 8-K | 2019-01-07 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On January 7, 2019, Nevro Corp. (“Nevro” or the “Company”) issued a press release announcing its preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2018. 7.01 Spokespersons of the Company plan to present the information in the presentation slides attached hereto as Exhibit 99.2 at various investor and analyst meetings scheduled during the week of January 7, 2019. | d687570d8k.htm |